Robin Swartz, COO & CBO at Voyager Therapeutics, Inc. (VYGR), sold 6,950 shares at $4.45 ($31K) on 2025-02-11, disclosed to the SEC on 2025-02-12.
Open-market sale of $31k VYGR by COO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-01-15 | $16K | — | Filing → |